Lipids Health Dis December 2011 PMID 22188761

Supplementation of arachidonic acid-enriched oil increases arachidonic acid contents in plasma phospholipids, but does not increase their metabolites and clinical parameters in Japanese healthy elderly individuals: a randomized controlled study.

Saki Kakutani, Yoshiyuki Ishikura, Norifumi Tateishi, Chika Horikawa, Hisanori Tokuda, Masanori Kontani, Hiroshi Kawashima, Yutaka Sakakibara, Yoshinobu Kiso, Hiroshi Shibata, Ikuo Morita

Download social card

Mentions

5
Peak: 2 in Oct 2025
across 3 sources since Aug 2021

Extended reach

36,086
potential audience

Total likes

34

Video views

1,830

Mentions per month

Aug 2021 – Oct 2025

Where it's discussed

  • YouTube2 videos
  • Facebook2 posts
  • X / Twitter1 posts

AI synopsis

What people are saying

Various discussions highlight the study's implications, with some emphasizing that increasing plasma ARA levels doesn't translate into health risks, evidenced by phrases like 'safe for the elderly'. Others mention the double-blind trial showing consumption of up to 720 mg ARA daily doesn’t increase inflammatory metabolites, underscoring a consensus on safety but less on broad clinical impact. The tone and word choices suggest a balanced view that acknowledges safety but questions additional benefits.

AgreementModerate agreement

Most posts agree that the study indicates ARA supplementation doesn't significantly alter clinical health markers, showing general acceptance of the findings.

InterestModerate interest

Discussion shows moderate curiosity about the safety and effects of ARA, particularly since the supplement seems safe without affecting inflammatory markers.

EngagementModerate engagement

Posters refer to specific aspects like the dose-dependent increase in plasma ARA and the washout period, demonstrating thoughtful engagement with the study’s methodology.

ImpactNeutral impact

While some recognize the study's findings as reassuring for elderly supplementation, others see limited practical change, reflecting a neutral impact overall.

Abstract in brief

  • ARA supplementation in healthy elderly Japanese individuals increased plasma phospholipid ARA levels in a dose-dependent manner but did not affect their metabolites or clinical markers related to cardiovascular, inflammatory, or allergic diseases.
  • The elevated ARA levels returned to baseline after a 4-week washout period, and no significant changes were observed in other fatty acids or clinical parameters during the study.
  • Overall, supplementing with ARA-enriched oil appears safe for the elderly, as it does not alter key metabolites or clinical indicators associated with inflammation, allergies, or cardiovascular health.

Top posts

Most liked on X and Bluesky
Simon Hill MSc, BSc
@theproof · X

Bonus: forgot to include RCT double blind placebo trial that showed consumption of up to 720 mg Arachidonic Acid a day didn’t increase inflammatory metabolites. https://t.co/qX1YOf0xGb

Aug 27, 2021 · 2 likes · 34,257 followers View post →

All mentions

Simon Hill MSc, BSc
@theproof · X

Bonus: forgot to include RCT double blind placebo trial that showed consumption of up to 720 mg Arachidonic Acid a day didn’t increase inflammatory metabolites. https://t.co/qX1YOf0xGb

Aug 27, 2021 · 2 likes · 34,257 followers View post →